Continuing Education Provider Approval:
Pre-Symposium Pain Management & Ethics Course

This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through the joint efforts between the American Association of Oral and Maxillofacial Surgeons and the Houston Society of Oral and Maxillofacial Surgeons and the University of Texas Health Science Center, Department of OMS.

American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

American Association of Oral and Maxillofacial Surgeons designates this activity for 3.0 continuing education credits.

AGD-Accepted Program Provider
FAGD/MAGD Credit
5/1/18 – 12/31/22 Provider ID# 214680

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Association of Oral and Maxillofacial Surgeons, the Houston Society of Oral and Maxillofacial Surgeons and the University of Texas Health Science Center, Department of OMS. The American Association of Oral and Maxillofacial Surgeons is accredited by the ACCME to provide continuing medical education for physicians.

The American Association of Oral and Maxillofacial Surgeons designates this live activity for a maximum of 3.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pre-Symposium Course Description & Objectives

Description
This presentation will provide an in-depth review of the clinical pharmacologic characteristics of opioids and other controlled substances utilized in pain control, including indications, contraindications, adverse effects, and drug-drug interactions regarding beneficial and adverse drugs. This presentation emphasizes safe and effective dosing and the proper dose regimens in the preoperative and postoperative care settings. Attendees can also expect to learn more about medicolegal and ethical considerations, including reasonable standards of care to be applied when prescribing controlled substances.

Objectives
Upon completion of the course, the dentist will be able to describe and apply the following during direct patient care:
• Recognize the indications and contraindications for specific opioids and other controlled substances used in pain management
• Use pre-emptive therapies to optimize intraoperative and postoperative pain control
• Identify drug-seeking behavior in patients
• Medicolegal and ethical considerations in dental pain management

Continuing Education Provider Approval:
Edward C. Hinds Symposium

This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through the joint efforts between the American Association of Oral and Maxillofacial Surgeons and the Houston Society of Oral and Maxillofacial Surgeons and the University of Texas Health Science Center, Department of OMS.

American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

American Association of Oral and Maxillofacial Surgeons designates this activity for 10.0 continuing education credits.

AGD-Accepted Program Provider
FAGD/MAGD Credit
5/1/18 – 12/31/22 Provider ID# 214680

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Association of Oral and Maxillofacial Surgeons, the Houston Society of Oral and Maxillofacial Surgeons and the University of Texas Health Science Center, Department of OMS. The American Association of Oral and Maxillofacial Surgeons is accredited by the ACCME to provide continuing medical education for physicians.

The American Association of Oral and Maxillofacial Surgeons designates this live activity for a maximum of 10.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Symposium Course Description & Objectives

The thirty-first Hinds Symposium will focus on an area of importance and interest to the oral and maxillofacial surgery practitioner.

The symposium will present a contemporary understanding of leukoplakia, oral mucosal lesions, oral manifestations of dermatological conditions, and an update on MRONJ. The symposium will also describe current and future therapies for these conditions including medical, surgical, and targeted gene and immune-therapeutic modalities.

Upon completion of this activity, the learner should be able to:
1) Discriminate between leukoplakia and other white lesions
2) Update knowledge of the etiopathogenesis of oral mucosal and common dermatologic conditions.
3) Appreciate recent experiences with MRONJ including causes, risks, drug holidays and assays to determine severity of disease.